NP-101 in combination with nivolumab and ipilimumab in metastatic extrapulmonary neuroendocrine carcinomas (EP-NECs): A pilot study

Endocrine-Related Cancer · Published 2026-04-21 · DOI 10.1530/erc-25-0232

Authors being retrieved — see the publisher record. https://doi.org/10.1530/erc-25-0232

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• The NET score: an interpretable AI-assisted prognostic score for mortality risk in lung neuroendocrine tumors · Endocrine-Related Cancer · 2026 · Same journal
• Multiple endocrine neoplasia type 5: emerging evidence and clinical perspectives · Endocrine-Related Cancer · 2026 · Same journal
• TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma · Endocrine-Related Cancer · 2026 · Same journal
• Is preoperative adrenoceptor blockade necessary in patients with paraganglioma? · Endocrine-Related Cancer · 2026 · Same journal
• Whole genome and exome sequencing of pancreatic NET to investigate PRRT response · Endocrine-Related Cancer · 2026 · Same journal
• The role of the B7 family in autoimmune thyroid diseases and thyroid cancer · Endocrine-Related Cancer · 2026 · Same journal
• Developing an epithelial signature for prognosis of papillary thyroid carcinoma · Endocrine-Related Cancer · 2026 · Same journal
• Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside · Endocrine-Related Cancer · 2026 · Same journal
• Adrenocortical cell and macrophage heterogeneity at single-cell spatial resolution in KCNJ5 -mutant aldosterone-producing adenomas · Endocrine-Related Cancer · 2026 · Same journal
• Associations of TILs and Genomic Alterations in HER2+ Early Breast Cancer · Endocrine-Related Cancer · 2026 · Same journal